The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Constitutive Expression of phVEGF 165 After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb Ischemia
Abstract
Background —Preclinical studies have indicated that angiogenic growth factors can stimulate the development of collateral arteries, a concept called “therapeutic angiogenesis.” The objectives of this phase 1 clinical trial were (1) to document the safety and feasibility of intramuscular gene transfer by use of naked plasmid DNA encoding an endothelial cell mitogen and (2) to analyze potential therapeutic benefits in patients with critical limb ischemia. Methods and Results —Gene transfer was performed in 10 limbs of 9 patients with nonhealing ischemic ulcers (n=7/10) and/or rest pain (n=10/10) due to peripheral arterial disease. A total dose of 4000 μg of naked plasmid DNA encoding the 165-amino-acid isoform of human vascular endothelial growth factor (phVEGF 165 ) was injected directly into the muscles of the ischemic limb. Gene expression was documented by a transient increase in serum levels of VEGF monitored by ELISA. The ankle-brachial index improved significantly (0.33±0.05 to 0.48±0.03, P =.02); newly visible collateral blood vessels were directly documented by contrast angiography in 7 limbs; and magnetic resonance angiography showed qualitative evidence of improved distal flow in 8 limbs. Ischemic ulcers healed or markedly improved in 4 of 7 limbs, including successful limb salvage in 3 patients recommended for below-knee amputation. Tissue specimens obtained from an amputee 10 weeks after gene therapy showed foci of proliferating endothelial cells by immunohistochemistry. PCR and Southern blot analyses indicated persistence of small amounts of plasmid DNA. Complications were limited to transient lower-extremity edema in 6 patients, consistent with VEGF enhancement of vascular permeability. Conclusions —These findings may be cautiously interpreted to indicate that intramuscular injection of naked plasmid DNA achieves constitutive overexpression of VEGF sufficient to induce therapeutic angiogenesis in selected patients with critical limb ischemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,115
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,061
Cited by
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., & Fowkes, F. G. R. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.12.037 · Cited by 8,191
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing
Barrientos, S., Stojadinovic, O., Golinko, M. S., Brem, H., & Tomic‐Canic, M. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2008.00410.x · Cited by 3,583
Vascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., & Fowkes, F. G. R. (2007) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2006.09.024 · Cited by 2,840
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,529
Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., & Isner, J. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3964 · Cited by 1,856
Self-citationVascular Endothelial Growth Factor and Angiogenesis
Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., & De Bruijn, E. A. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.3 · Cited by 1,824
Polymeric system for dual growth factor delivery
Richardson, T. P., Peters, M. C., Ennett, A. B., & Mooney, D. J. (2001) · Nature Biotechnology · doi:10.1038/nbt1101-1029 · Cited by 1,752
Tateishi-Yuyama, E., Matsubara, H., Murohara, T., Ikeda, U., Shintani, S., Masaki, H., Amano, K., Kishimoto, Y., Yoshimoto, K., Akashi, H., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09670-8 · Cited by 1,734
Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1
Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T. N., Yancopoulos, G. D., & McDonald, D. M. (1999) · Science · doi:10.1126/science.286.5449.2511 · Cited by 1,359
The Role of Vascular Endothelial Growth Factor in Wound Healing
Bao, P., Kodra, A., Tomic-Canic, M., Golinko, M. S., Ehrlich, H. P., & Brem, H. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2008.04.023 · Cited by 1,211
Molecular and biological properties of vascular endothelial growth factor
Ferrara, N. (1999) · Journal of Molecular Medicine · doi:10.1007/s001099900019 · Cited by 1,158
The VIVA Trial: Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis
Henry, T. D., Annex, B. H., McKendall, G. R., Azrin, M. A., Lopez, J. J., Giordano, F. J., Shah, P. K., Willerson, J. T., Benza, R. L., Berman, D. S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000061911.47710.8a · Cited by 1,025
Therapeutic strategies for enhancing angiogenesis in wound healing
Veith, A. P., Henderson, K., Spencer, A., Sligar, A. D., & Baker, A. B. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.09.010 · Cited by 1,021
Clinical applications of angiogenic growth factors and their inhibitors
Ferrara, N., & Alitalo, K. (1999) · Nature Medicine · doi:10.1038/70928 · Cited by 1,004
“In a subsequent study, the VEGF 165 plasmid cDNA was injected intramuscularl”
MethodLosordo, D. W., Vale, P. R., Symes, J. F., Dunnington, C. H., Esakof, D. D., Maysky, M., Ashare, A. B., Lathi, K., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.98.25.2800 · Cited by 987
Self-citationTransplanted cord blood–derived endothelial precursor cells augment postnatal neovascularization
Murohara, T., Ikeda, H., Duan, J., Shintani, S., Sasaki, K.-I., Eguchi, H., Onitsuka, I., Matsui, K., & Imaizumi, T. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8296 · Cited by 897
Ouriel, K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06351-6 · Cited by 865
Griffioen, A. W., & Molema, G. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01448-0 · Cited by 842
Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
Isner, J. M., & Asahara, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6889 · Cited by 770
Self-citationRole of vascular endothelial growth factor in the regulation of angiogenesis
Ferrara, N. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00610.x · Cited by 731
Marti, H. J. H., Bernaudin, M., Bellail, A., Schoch, H., Euler, M., Petit, E., & Risau, W. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64964-4 · Cited by 680
“Stimulation of physiological collateral growth and angiogenesis by exogenous VEGF has shown to be a promising strategy for the treatment of these diseases.(65,66) This strategy may also hold a similar promise for the treatment of stroke.”
BackgroundIwaguro, H., Yamaguchi, J.-I., Kalka, C., Murasawa, S., Masuda, H., Hayashi, S.-I., Silver, M., Li, T., Isner, J. M., & Asahara, T. (2002) · Circulation · doi:10.1161/hc0602.103673 · Cited by 588
Self-citationKalka, C., Masuda, H., Takahashi, T., Gordon, R., Tepper, O., Gravereaux, E., Pieczek, A., Iwaguro, H., Hayashi, S.-I., Isner, J. M., et al. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1198 · Cited by 564
Self-citationFujio, Y., & Walsh, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16349 · Cited by 553
Self-citationHedman, M., Hartikainen, J., Syvänne, M., Stjernvall, J., Hedman, A., Kivelä, A., Vanninen, E., Mussalo, H., Kauppila, E., Simula, S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000070540.80780.92 · Cited by 537
Zisch, A. H., Lutolf, M. P., Ehrbar, M., Raeber, G. P., Rizzi, S. C., Davies, N., Schmökel, H., Bezuidenhout, D., Djonov, V., Zilla, P., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-1041fje · Cited by 534
Lederman, R. J., Mendelsohn, F. O., Anderson, R. D., Saucedo, J. F., Tenaglia, A. N., Hermiller, J. B., Hillegass, W. B., Rocha-Singh, K., Moon, T. E., Whitehouse, M., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08937-7 · Cited by 511
Meyer, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.2.363 · Cited by 509
Wound healing: Biologic features and approaches to maximize healing trajectories
Robson, M. C., Steed, D. L., & Franz, M. G. (2001) · Current Problems in Surgery · doi:10.1067/msg.2001.111167 · Cited by 503
Pathological angiogenesis: mechanisms and therapeutic strategies
Dudley, A. C., & Griffioen, A. W. (2023) · Angiogenesis · doi:10.1007/s10456-023-09876-7 · Cited by 495
Vascular Endothelial Growth Factors
Ylä-Herttuala, S., Rissanen, T. T., Vajanto, I., & Hartikainen, J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.053 · Cited by 480
Rescue of Diabetes-Related Impairment of Angiogenesis by Intramuscular Gene Therapy with Adeno-VEGF
Rivard, A., Silver, M., Chen, D., Kearney, M., Magner, M., Annex, B., Peters, K., & Isner, J. M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65282-0 · Cited by 474
Self-citationLosordo, D. W., Vale, P. R., Hendel, R. C., Milliken, C. E., Fortuin, F. D., Cummings, N., Schatz, R. A., Asahara, T., Isner, J. M., & Kuntz, R. E. (2002) · Circulation · doi:10.1161/01.cir.0000015982.70785.b7 · Cited by 466
Self-citationAugmentation of Postnatal Neovascularization With Autologous Bone Marrow Transplantation
Shintani, S., Murohara, T., Ikeda, H., Ueno, T., Sasaki, K.-I., Duan, J., & Imaizumi, T. (2001) · Circulation · doi:10.1161/01.cir.103.6.897 · Cited by 460
Vasculogenesis and Angiogenesis
Patan, S. (2004) · Cancer Treatment and Research · doi:10.1007/978-1-4419-8871-3_1 · Cited by 430
Miquerol, L., Langille, B. L., & Nagy, A. (2000) · Development · doi:10.1242/dev.127.18.3941 · Cited by 429
Microbubbles and ultrasound: from diagnosis to therapy
DIJKMANS, P., JUFFERMANS, L., MUSTERS, R., VANWAMEL, A., TENCATE, F., VANGILST, W., VISSER, C., DEJONG, N., & KAMP, O. (2004) · European Journal of Echocardiography · doi:10.1016/j.euje.2004.02.001 · Cited by 420
Pettersson, A., Nagy, J. A., Brown, L. F., Sundberg, C., Morgan, E., Jungles, S., Carter, R., Krieger, J. E., Manseau, E. J., Harvey, V. S., et al. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780013 · Cited by 417
Gene transfer as a tool to induce therapeutic vascular growth
Ylä-Herttuala, S., & Alitalo, K. (2003) · Nature Medicine · doi:10.1038/nm0603-694 · Cited by 404
Taniyama, Y., Tachibana, K., Hiraoka, K., Aoki, M., Yamamoto, S., Matsumoto, K., Nakamura, T., Ogihara, T., Kaneda, Y., & Morishita, R. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301678 · Cited by 394
Isner, J. M., Baumgartner, I., Rauh, G., Schainfeld, R., Blair, R., Manor, O., Razvi, S., & Symes, J. F. (1998) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(98)70022-9 · Cited by 392
Self-citationRecent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics
Ding, D., & Zhu, Q. (2018) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.12.036 · Cited by 386
Vasculogenesis and Angiogenesis as Mechanisms of Vascular Network Formation, Growth and Remodeling
Patan, S. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006493130855 · Cited by 382
Nishida, T., Shimokawa, H., Oi, K., Tatewaki, H., Uwatoku, T., Abe, K., Matsumoto, Y., Kajihara, N., Eto, M., Matsuda, T., et al. (2004) · Circulation · doi:10.1161/01.cir.0000148849.51177.97 · Cited by 381
Ylä-Herttuala, S., & Martin, J. F. (2000) · The Lancet · doi:10.1016/s0140-6736(99)04180-x · Cited by 375
Mäkinen, K., Manninen, H., Hedman, M., Matsi, P., Mussalo, H., Alhava, E., & Ylä-Herttuala, S. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0638 · Cited by 374
Varu, V. N., Hogg, M. E., & Kibbe, M. R. (2010) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.08.073 · Cited by 362
Therapeutic Angiogenesis and Vasculogenesis for Ischemic Disease: Part I: Angiogenic Cytokines
Losordo, D. W., & Dimmeler, S. (2004) · Circulation · doi:10.1161/01.cir.0000128595.79378.fa · Cited by 357
Covalently conjugated VEGF–fibrin matrices for endothelialization
Zisch, A. H., Schenk, U., Schense, J. C., Sakiyama-Elbert, S. E., & Hubbell, J. A. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00266-8 · Cited by 350
Advances in surgical applications of growth factors for wound healing
Yamakawa, S., & Hayashida, K. (2019) · Burns & Trauma · doi:10.1186/s41038-019-0148-1 · Cited by 347
Witzenbichler, B., Asahara, T., Murohara, T., Silver, M., Spyridopoulos, I., Magner, M., Principe, N., Kearney, M., Hu, J.-S., & Isner, J. M. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65582-4 · Cited by 346
Self-citationGrowth factors in the treatment of diabetic foot ulcers
Bennett, S. P., Griffiths, G. D., Schor, A. M., Leese, G. P., & Schor, S. L. (2003) · British Journal of Surgery · doi:10.1002/bjs.4019 · Cited by 338
Gene therapy: the first decade
Mountain, A. (2000) · Trends in Biotechnology · doi:10.1016/s0167-7799(99)01416-x · Cited by 334
Nikol, S., Baumgartner, I., Van Belle, E., Diehm, C., Visoná, A., Capogrossi, M. C., Ferreira-Maldent, N., Gallino, A., Graham Wyatt, M., Dinesh Wijesinghe, L., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.33 · Cited by 333
Self-citationStimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease
van Royen, N. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00206-6 · Cited by 329
Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox.
Duh, E., & Aiello, L. P. (1999) · Diabetes · doi:10.2337/diabetes.48.10.1899 · Cited by 319
Vale, P. R., Losordo, D. W., Milliken, C. E., Maysky, M., Esakof, D. D., Symes, J. F., & Isner, J. M. (2000) · Circulation · doi:10.1161/01.cir.102.9.965 · Cited by 318
Self-citationKusumanto, Y. H., van Weel, V., Mulder, N. H., Smit, A. J., van den Dungen, J. J. A. M., Hooymans, J. M. M., Sluiter, W. J., Tio, R. A., Quax, P. H. A., Gans, R. O. B., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.683 · Cited by 318
Reversal of experimental diabetic neuropathy by VEGF gene transfer
Schratzberger, P., Walter, D. H., Rittig, K., Bahlmann, F. H., Pola, R., Curry, C., Silver, M., Krainin, J. G., Weinberg, D. H., Ropper, A. H., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12188 · Cited by 310
Self-citationIsner, J. M. (2002) · Nature · doi:10.1038/415234a · Cited by 309
Self-citationVale, P. R., Losordo, D. W., Milliken, C. E., McDonald, M. C., Gravelin, L. M., Curry, C. M., Esakof, D. D., Maysky, M., Symes, J. F., & Isner, J. M. (2001) · Circulation · doi:10.1161/01.cir.103.17.2138 · Cited by 307
Self-citationLocal drug and gene delivery through microbubbles
Unger, E. C., Hersh, E., Vannan, M., Matsunaga, T. O., & McCreery, T. (2001) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2001.26443 · Cited by 307
Powell, R. J., Simons, M., Mendelsohn, F. O., Daniel, G., Henry, T. D., Koga, M., Morishita, R., & Annex, B. H. (2008) · Circulation · doi:10.1161/circulationaha.107.727347 · Cited by 303
Role of vascular endothelial growth factor in diabetic vascular complications
Aiello, L. P., & Wong, J.-S. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07718.x · Cited by 293
Yoon, Y.-S., Uchida, S., Masuo, O., Cejna, M., Park, J.-S., Gwon, H.-C., Kirchmair, R., Bahlman, F., Walter, D., Curry, C., et al. (2005) · Circulation · doi:10.1161/01.cir.0000162472.52990.36 · Cited by 288
Self-citationDistler, O., del Rosso, A., Giacomelli, R., Cipriani, P., Conforti, M. L., Guiducci, S., Gay, R. E., Michel, B. A., Brühlmann, P., Müller-Ladner, U., et al. (2002) · Arthritis Research & Therapy · doi:10.1186/ar596 · Cited by 281
Kalka, C., Tehrani, H., Laudenberg, B., Vale, P. R., Isner, J. M., Asahara, T., & Symes, J. F. (2000) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(00)01633-7 · Cited by 278
Self-citationHuman Studies of Angiogenic Gene Therapy
Gupta, R., Tongers, J., & Losordo, D. W. (2009) · Circulation Research · doi:10.1161/circresaha.109.200386 · Cited by 276
VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema
Yoon, Y.-S., Murayama, T., Gravereaux, E., Tkebuchava, T., Silver, M., Curry, C., Wecker, A., Kirchmair, R., Hu, C. S., Kearney, M., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15830 · Cited by 270
Self-citationMorishita, R., Nakamura, S., Hayashi, S.-I., Taniyama, Y., Moriguchi, A., Nagano, T., Taiji, M., Noguchi, H., Takeshita, S., Matsumoto, K., et al. (1999) · Hypertension · doi:10.1161/01.hyp.33.6.1379 · Cited by 267
Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders
Shahryari, A., Saghaeian Jazi, M., Mohammadi, S., Razavi Nikoo, H., Nazari, Z., Hosseini, E. S., Burtscher, I., Mowla, S. J., & Lickert, H. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00868 · Cited by 262
Therapeutic lymphangiogenesis with human recombinant VEGF‐C
Szuba, A., Skobe, M., Karkkainen, M. J., Shin, W. S., Beynet, D. P., Rockson, N. B., Dakhil, N., Spilman, S., Goris, M. L., Strauss, H. W., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0401fje · Cited by 260
Postischemic Revascularization: From Cellular and Molecular Mechanisms to Clinical Applications
Silvestre, J.-S., Smadja, D. M., & Lévy, B. I. (2013) · Physiological Reviews · doi:10.1152/physrev.00006.2013 · Cited by 255
VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond
Giacca, M., & Zacchigna, S. (2012) · Gene Therapy · doi:10.1038/gt.2012.17 · Cited by 252
Waltenberger, J., Lange, J., & Kranz, A. (2000) · Circulation · doi:10.1161/01.cir.102.2.185 · Cited by 252
Wang, Y. (2004) · Brain · doi:10.1093/brain/awh325 · Cited by 221
“Preliminary clinical studies for the treatment of peripheral arterial occlusive diseases (Baumgartner et al., 1998) and myocardial ischaemia (Hendel et al., 2000) were promising; however, results from the larger VIVA trial were somewhat disappointing (Henry et al., 2003).”
InfluentialSupp, D. M., Supp, A. P., Boyce, S. T., & Bell, S. M. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00824.x · Cited by 120
Expression of Nerve Growth Factor and trkA After Transient Focal Cerebral Ischemia in Rats
Lee, T.-H., Kato, H., Chen, S.-T., Kogure, K., & Itoyama, Y. (1998) · Stroke · doi:10.1161/01.str.29.8.1687 · Cited by 103
Klueh, U., Dorsky, D. I., & Kreutzer, D. L. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.04.017 · Cited by 87
Stimulation of Angiogenesis by Cyr61 Gene: A New Therapeutic Candidate
Fataccioli, V., Abergel, V., Wingertsmann, L., Neuville, P., Spitz, E., Adnot, S., Calenda, V., & Teiger, E. (2002) · Human Gene Therapy · doi:10.1089/10430340260185094 · Cited by 58
Medical Treatment of Peripheral Artery Disease
Gornik, H. L., & Creager, M. A. (2013) · Vascular Medicine: A Companion to Braunwald's Heart Disease · doi:10.1016/b978-1-4377-2930-6.00019-7 · Cited by 12
Metadata
- Authors
- Baumgartner, I., Pieczek, A., Manor, O., Blair, R., Kearney, M., Walsh, K., & Isner, J. M.
- Venue
- Circulation
- Published
- 1998-03-31
- Volume
- 97
- Issue
- 12
- Pages
- 1114-1123
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2015789556
- Cited by
- 1,098
- References
- 45
- FWCI
- 31.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.